OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tanshinone IIA regulates the TGF‑β1/Smad signaling pathway to ameliorate non‑alcoholic steatohepatitis‑related fibrosis
Lianjie Xu, Yurong Zhang, Nengbo Ji, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Lianjie Xu, Yurong Zhang, Nengbo Ji, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 86
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 86
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
Harnessing nature's arsenal: Targeting the TGF-β/Smad Cascade with novel natural anti-fibrotic agents
Maohua Chen, Linjiang Song, Anqi Zeng
Fitoterapia (2025) Vol. 181, pp. 106372-106372
Closed Access
Maohua Chen, Linjiang Song, Anqi Zeng
Fitoterapia (2025) Vol. 181, pp. 106372-106372
Closed Access
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
Xue Li, Xinyi Xu, Sian Tao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Xue Li, Xinyi Xu, Sian Tao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3/CPT1A-dependent fatty acid oxidation in hepatic stellate cells
Zibo Li, Yaqiu Zheng, Lin Zhang, et al.
Chemico-Biological Interactions (2024) Vol. 399, pp. 111119-111119
Closed Access | Times Cited: 2
Zibo Li, Yaqiu Zheng, Lin Zhang, et al.
Chemico-Biological Interactions (2024) Vol. 399, pp. 111119-111119
Closed Access | Times Cited: 2
Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression
Kohei Yamada, Tomokazu Tanaka, Keita Kai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11546-11546
Open Access | Times Cited: 4
Kohei Yamada, Tomokazu Tanaka, Keita Kai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11546-11546
Open Access | Times Cited: 4
Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis
Dajin Pi, Liang Zheng, Jinyue Pan, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1026-1026
Open Access | Times Cited: 1
Dajin Pi, Liang Zheng, Jinyue Pan, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1026-1026
Open Access | Times Cited: 1
Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor Through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression
Kohei Yamada, Tomokazu Tanaka, Keita Kai, et al.
(2023)
Open Access | Times Cited: 3
Kohei Yamada, Tomokazu Tanaka, Keita Kai, et al.
(2023)
Open Access | Times Cited: 3
Tanshinone Alleviates UVA-induced Melanogenesis in Melanocytes via the Nrf2-regulated Antioxidant Defense Signaling Pathway
Jiaoquan Chen, Zonghao Yin, Nanji Yu, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1529-1539
Closed Access | Times Cited: 3
Jiaoquan Chen, Zonghao Yin, Nanji Yu, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1529-1539
Closed Access | Times Cited: 3
Efficacy and safety of Huatan Qushi Huoxue Fang granules on obese non-alcoholic fatty liver disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Lihui Zhang, Sutong Liu, Qing Zhao, et al.
Research Square (Research Square) (2024)
Closed Access
Lihui Zhang, Sutong Liu, Qing Zhao, et al.
Research Square (Research Square) (2024)
Closed Access
